Evidence map›Paper›PMID 41411522›Full record

ArticleBlood advances2026

Real-world comparison of progression-free survival and time to next therapy in 761 patients with newly diagnosed multiple myeloma.

Hira Mian, Mariano Arribas, Rafael Fonseca, Erin Mutterback, Omar Shahid, Rohan Gouda, Gregory R Pond, Alissa Visram

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Hira MianDepartment of Oncology, McMaster University, Hamilton, ON, Canada.ORCID 0000-0003-1584-1067
Mariano ArribasDepartment of Hematology/Oncology, Mayo Clinic, Phoenix, AZ.ORCID 0000-0003-1859-7098
Rafael FonsecaDepartment of Hematology/Oncology, Mayo Clinic, Phoenix, AZ.ORCID 0000-0002-5938-3769
Erin MutterbackDepartment of Hematology, University of Ottawa, Ottawa, ON, Canada.ORCID 0009-0000-6431-4226
Omar ShahidDepartment of Oncology, McMaster University, Hamilton, ON, Canada.ORCID 0009-0000-3427-7188
Rohan GoudaDepartment of Oncology, McMaster University, Hamilton, ON, Canada.ORCID 0009-0002-2974-388X
Gregory R PondDepartment of Oncology, McMaster University, Hamilton, ON, Canada.ORCID 0000-0003-1033-0882
Alissa VisramDepartment of Oncology, McMaster University, Hamilton, ON, Canada.ORCID 0000-0002-7201-4642

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41411522
PMCPMC12927043

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.